Björn Lundin
21 – 30 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)
(
- Contribution to journal › Article
-
Mark
Biomarkers of Cartilage and Bone Damage as a Measure of Joint Damage in Haemophilia.
(
- Contribution to journal › Published meeting abstract
-
Mark
Digital scoring of haemophilic arthropathy using radiographs is feasible
(
- Contribution to journal › Article
-
Mark
Biomarkers of cartilage and bone damage as a measure of joint damage in haemophilia
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.655-656(
- Contribution to journal › Published meeting abstract
-
Mark
Digital scoring of haemophilic arthropathy using radiographs: Is it feasible?
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.698-699(
- Contribution to journal › Published meeting abstract
-
Mark
A 10-year, randomized, clinical trial on prophylaxis vs. on-demand treatment in children with haemophilia A: the E.S.P.R.I.T. study
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.99-99(
- Contribution to journal › Published meeting abstract
-
Mark
Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.
(
- Contribution to journal › Article
- 2007
-
Mark
MRI assessment of haemophilic arthropathy
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Gadolinium Contrast Agent is of Limited Value for Magnetic Resonance Imaging Assessment of Synovial Hypertrophy in Hemophiliacs.
(
- Contribution to journal › Article
-
Mark
The economics of haemophilia prophylaxis; governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.
(
- Contribution to journal › Article